Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

布洛芬缓释胶囊 - NMPA Drug Approval Details

Approvals/NMPA/Ibuprofen Sustained-release Capsules

Approved

化学药品

Ibuprofen Sustained-release Capsules

国大（吉林）制药集团有限公司🇨🇳 National Medical Products Administration

Approval Date: Feb 25, 2026
Approval ID: 8mfLCMOIOHW
Company: 国大（吉林）制药集团有限公司
Type: 化学药品

Approval Details

Approval Id: 8mfLCMOIOHW
Approval Number: 国药准字H20263478
Generic Name: 布洛芬缓释胶囊
Generic Name En: Ibuprofen Sustained-release Capsules
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 0.3g
Reg Date: 2026-02-25
Company Name: 国大（吉林）制药集团有限公司
Company Address: 长春市中韩(长春)国际合作示范区航空街3999号办公楼403室
Production Company Name: 天津市力生制药厂
Production Company Address: 天津市西青经济开发区赛达北一道16号
Company Detail Path: /organization/7e24c38011043a2b/guo-da-ji-lin-zhi-yao-ji-tuan-you-xian-gong-si
Production Company Detail Path: /organization/d95d7a389871bcf4/tian-jin-shi-li-sheng-zhi-yao-han

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 25, 2026

Approval ID

8mfLCMOIOHW

Type

化学药品

Back to NMPA Approvals